Prosecution Insights
Last updated: May 29, 2026
Application No. 17/612,183

ORGANIC LIGHT EMITTING DEVICE

Non-Final OA §103
Filed
Nov 17, 2021
Priority
Nov 29, 2019 — RE 10-2019-0157386 +3 more
Examiner
GARRETT, DAWN L
Art Unit
1786
Tech Center
1700 — Chemical & Materials Engineering
Assignee
LG Chem, Ltd.
OA Round
3 (Non-Final)
72%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
82%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
695 granted / 960 resolved
+7.4% vs TC avg
Moderate +10% lift
Without
With
+10.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
36 currently pending
Career history
1026
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
63.8%
+23.8% vs TC avg
§102
3.6%
-36.4% vs TC avg
§112
12.0%
-28.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 960 resolved cases

Office Action

§103
DETAILED ACTION Response to Amendment The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This office action is responsive to the amendment dated August 29, 2025. Claim 1 was amended. Claims 1-13 are pending. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-12 are rejected under 35 U.S.C. 103 as being unpatentable over Kim et al. (US 2022/0006019 A1). Kim et al. teaches organic electroluminescent devices comprising a plurality of light emitting materials including anthracene compound(s) of Formula 1 and second compound(s) of Formula 2 (see par. 8) in a light emitting layer in a device structure (see par. 71, 72). . Formula (1) is the following per instant Formulas “1”: PNG media_image1.png 234 320 media_image1.png Greyscale (see par. 8). R1 to R8 are defined in par. 12, L1 and L2 are defined in par. 10, and Ar1 and Ar2 are defined in par. 11. “Dn” represents n hydrogens are replaced with deuterium (see par. 13). More specifically, Formula 1 includes at least H-60 per instant Formula 1-1: PNG media_image2.png 158 320 media_image2.png Greyscale (middle page 16) H-58 per per instant Formula 1-2: PNG media_image3.png 148 290 media_image3.png Greyscale (top page 16). H-260 per instant Formula 1-3: PNG media_image4.png 140 296 media_image4.png Greyscale (top page 42). Formula 2 is the following (see par. 14-19) per instant Formula 2: PNG media_image5.png 138 224 media_image5.png Greyscale . In Formula 2, Y1 is B and X1 and X2 are nitrogen (see par. 17-18). More specifically Formula (2) may be Formula (2-1) where R24 and R25 “may be linked to an adjacent substituent to form a ring (see par. 55-56) per instant Y5 bridging group of instant Formula 2 and may be further substituted per instant Z7 and Z8 (see par. 56): PNG media_image6.png 174 254 media_image6.png Greyscale . Note that X1 and X2 as N may be bonded to an aryl group per instant groups R4 and R5. Regarding claims 2 and 3, Formula 1 compound comprise n number of deuterium, which may include 30% deuteration of instant claim 2 and/or deuteration corresponding to instant claim 3 (see Formula 1 above). Regarding claim 4, Kim et al. teaches “at least one of first compound”, which includes using two of the anthracene compounds of Formula 1 (see par. 8). Regarding claims 5-7, the above discussed Kim et al. compounds H-58, H-260, and H-60 read upon compounds of the claims, respectively. Regarding claim 8, in Formula 2, X1 and X2 are NR (see par. 14 and 18). The R may include at least C6 aryl, which includes phenyl (see par. 19, 25). Regarding claim 9, Formula 2 may comprise deuterium (see par. 16-19, 29). Regarding claim 10, Kim et al. as discussed above teaches at least H-60 per instant Formula 1-1 where “n” deuteriums may be present: PNG media_image2.png 158 320 media_image2.png Greyscale (middle page 16). Regarding claim 11, Kim et al. as discussed above teaches at least H-58 per instant Formula 1-2 where “n” deuteriums may be present: PNG media_image3.png 148 290 media_image3.png Greyscale (top page 16). Regarding claim 12, Kim et al. as discussed above teaches at least H-260 per instant Formula 1-3: PNG media_image4.png 140 296 media_image4.png Greyscale (top page 42). While Kim et al. does not appear to teach an example device where a specific Formula 2 compound with R24 and R25 joined together was selected for a light emitting layer of a device in combination with Formula 1 anthracene compound(s), given the teachings of the reference, it would have been obvious to one of ordinary skill in the art prior to the effective filing date of the instant invention to select materials of the reference for a device structure, choosing as the compounds, those described above, wherein the resultant compounds for a light emitting layer would also meet the limitations of the instant claims. One would expect to achieve an operational light emitting device within the disclosure of Kim et al. with a predictable result and a reasonable expectation of success. Claims 1-13 are rejected under 35 U.S.C. 103 as being unpatentable over Kim et al. (US 2022/0006019 A1) in view of Yuuki (US 2020/0185626 A1). Kim et al. teaches organic electroluminescent devices comprising a plurality of light emitting materials including anthracene compound(s) of Formula 1 and second compound(s) of Formula 2 (see par. 8) in a light emitting layer in a device structure (see par. 71, 72). . Formula (1) is the following per instant Formulas “1”: PNG media_image1.png 234 320 media_image1.png Greyscale (see par. 8). R1 to R8 are defined in par. 12, L1 and L2 are defined in par. 10, and Ar1 and Ar2 are defined in par. 11. Dn represents n hydrogens are replaced with deuterium (see par. 13). More specifically, Formula 1 includes at least H-60 per instant Formula 1-1: PNG media_image2.png 158 320 media_image2.png Greyscale (middle page 16) H-58 per per instant Formula 1-2: PNG media_image3.png 148 290 media_image3.png Greyscale (top page 16). H-260 per instant Formula 1-3: PNG media_image4.png 140 296 media_image4.png Greyscale (top page 42). Regarding claims 2 and 3, Formula 1 compound comprise n number of deuterium, which may include 30% deuteration of instant claim 2 and/or deuteration corresponding to instant claim 3 (see Formula 1 above). Regarding claim 4, Kim et al. teaches “at least one of first compound”, which includes using two of the anthracene compounds of Formula 1 (see par. 8). Regarding claims 5-7, the above discussed Kim et al. compounds H-58, H-260, and H-60 read upon compounds of the claims, respectively. Regarding claim 10, Kim et al. as discussed above teaches at least H-60 per instant Formula 1-1 where “n” deuteriums may be present: PNG media_image2.png 158 320 media_image2.png Greyscale (middle page 16). Regarding claim 11, Kim et al. as discussed above teaches at least H-58 per instant Formula 1-2 where “n” deuteriums may be present: PNG media_image3.png 148 290 media_image3.png Greyscale (top page 16). Regarding claim 12, Kim et al. as discussed above teaches at least H-260 per instant Formula 1-3: PNG media_image4.png 140 296 media_image4.png Greyscale (top page 42). Regarding claims 1, 8, 9, and 13 instant Formula 2 compounds, Kim et al. teaches Formula 2 is the following (see par. 14-19): PNG media_image5.png 138 224 media_image5.png Greyscale . In Formula 2, Y1 is B and X1 and X2 are nitrogen (see par. 17-18). More specifically Formula (2) may be Formula (2-1) where R24 and R25 “may be linked to an adjacent substituent to form a ring (see par. 55-56) per instant Y5 bridging group of instant Formula 2 and may be further substituted per instant Z7 and Z8 (see par. 56): PNG media_image6.png 174 254 media_image6.png Greyscale . Note that X1 and X2 as N may be bonded to an aryl group per instant groups R4 and R5. However, it is not seen where Kim et al. teaches a specific Formula 2 example compound the same as instant claim 13. In analogous art, Yuuki teaches Formula 2 compounds for use in an emission layer of a light emitting device (see Yuuki abstract and par. 71): PNG media_image7.png 176 306 media_image7.png Greyscale . In the formula, Y may be boron, Z1 and Z2 may be nitrogen (see Yuuki par. 63), R1 and R2 as a pair may be -Si(Ra)2- where Ra is aryl (see Yuuki par. 73, 66). R3 may be alkyl methyl (see Yuuki par. 72, 56). The compound with these selected defined groups is at least the same as the following compound of instant claim 13: PNG media_image8.png 128 106 media_image8.png Greyscale (see last page of instant claim set, labeled page 127 in 8/29/2025 claim set). Further, a deuterium may be included per instant claim 9 (see Yuuki par. 72). It would have been obvious to one ordinary skill in the art before the effective filing date to have selected a Formula 2 emission layer compound defined by Yuuki as an emission layer material in a device according to Kim et al., because one would expect Yuuki formula 2 compounds to be similarly useful for emission in a light emitting layer is a device structure according to Kim et al., which teaches a boron and nitrogen containing derivative is desirable for use in a light emitting layer. One would expect to achieve an operational device including materials according to Kim et al. and Yuuki with a predictable result and a reasonable expectation of success. Response to Arguments Applicant's arguments filed August 29, 2025 have been fully considered but they are not persuasive. While the claims were somewhat narrowed in scope in the amendment, applicant continues to claim a large number of possible anthracene derivative and boron derivatives. On page 131 of the remarks, applicant argues “the OLED including the claimed host and dopant in its light emitting layer provides unexpectedly advantageous and superior results compared to the compounds of Kim”. In response, the few comparative compounds discussed are not considered commensurate in scope with the fair teachings of Kim. Additionally, while applicant sets forth several inventive examples, none of the claims are limited to only these very specific compounds and/or combinations of compounds. The cited comparisons of Ex. 76 to 78 to Comparative Ex. 1 to 5 in the remarks do not clearly show that the very specific selection of particular groups on an anthracene or boron derivative attribute to unexpected results commensurate with the breadth of claimed compounds. Also, too many variables and groups differ among the “inventive” and “comparative” examples to show the selection of groups upon an anthracene and groups/bonding of the boron derivatives (i.e. including a Y5 bridge in instant Formula 2) specifically selected and combined in the “inventive” examples clearly provided unexpectedly improved results. The office submits that examples relied on by applicant as evidence of unexpected results do not provide an adequate basis to support a conclusion that other embodiments falling within the scope of the claims will behave in the same manner, and therefore, the evidence is not persuasive of nonobviousness because it is not commensurate in scope with the claims. (See In re Kao, 639 F.3d 1057, 1068 (Fed. Cir. 2011).) Further, the arguments with respect to the rejection over Kim in view of Yuuki are not considered persuasive as no specific arguments with respect to material taught by Yuuki were set forth. Case law holds that the selection of a known material based on its suitability for its intended use supports prima facie obviousness. Sinclar & Carroll Co vs. Interchemical Corp., 325 US 327, 65 USPQ 297 (1045). Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Dawn Garrett whose telephone number is (571)272-1523. The examiner can normally be reached Monday through Thursday (Eastern Time). If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Boyd can be reached at 571-272-7783. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DAWN L GARRETT/Primary Examiner, Art Unit 1786
Read full office action

Prosecution Timeline

Show 3 earlier events
Jun 18, 2025
Response Filed
Jun 18, 2025
Response after Non-Final Action
Aug 29, 2025
Response Filed
Nov 26, 2025
Final Rejection mailed — §103
Feb 25, 2026
Response after Non-Final Action
Feb 25, 2026
Request for Continued Examination
Mar 04, 2026
Response after Non-Final Action
May 27, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12622131
ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY PANEL, AND DISPLAY APPARATUS
3y 10m to grant Granted May 05, 2026
Patent 12612418
ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
4y 5m to grant Granted Apr 28, 2026
Patent 12615905
ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY PANEL, AND DISPLAY APPARATUS
3y 10m to grant Granted Apr 28, 2026
Patent 12595256
COMPOSITION FOR ORGANIC ELECTRONIC DEVICES
5y 4m to grant Granted Apr 07, 2026
Patent 12598910
COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME
4y 7m to grant Granted Apr 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
72%
Grant Probability
82%
With Interview (+10.1%)
3y 5m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 960 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month